Lyell Immunopharma (LYEL) Amortizatization of Intangibles (2020 - 2026)

Lyell Immunopharma (LYEL) has 7 years of Amortizatization of Intangibles data on file, last reported at $886000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 48.64% year-over-year to $886000.0; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (down 65.78% YoY), and the FY2025 full-year result was $5.0 million, down 66.22% from the prior year.
• Amortizatization of Intangibles fell to $886000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.4 million in Q1 2024 to a low of -$475000.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.7 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles jumped 998.27% in 2023 and plunged 71.87% in 2025, its largest moves.
• Tracing LYEL's Amortizatization of Intangibles over 5 years: stood at $1.2 million in 2022, then surged by 180.13% to $3.4 million in 2023, then slipped by 12.38% to $3.0 million in 2024, then slumped by 64.25% to $1.1 million in 2025, then decreased by 16.42% to $886000.0 in 2026.
• Business Quant data shows LYEL's Amortizatization of Intangibles at $886000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.